vs
Nerdy Inc.（NRDY）与Xeris Biopharma Holdings, Inc.（XERS）财务数据对比。点击上方公司名可切换其他公司
Xeris Biopharma Holdings, Inc.的季度营收约是Nerdy Inc.的1.7倍（$85.8M vs $49.1M），Xeris Biopharma Holdings, Inc.净利率更高（12.9% vs -18.8%，领先31.7%），Xeris Biopharma Holdings, Inc.同比增速更快（42.8% vs 2.3%），过去两年Xeris Biopharma Holdings, Inc.的营收复合增速更高（45.3% vs -4.4%）
Nerdy Inc.是总部位于美国的知名教育科技企业，旗下运营Varsity Tutors等在线学习平台，提供一对一实时辅导、点播课程、备考资源及技能培训内容，服务K12学生、高校学习者及职场人士，覆盖多类学业与职业能力提升需求。
Xeris Biopharma Holdings是一家专业生物制药企业，专注于开发和商业化罕见内分泌疾病、代谢疾病及皮肤病领域的靶向治疗药物，面向全球市场，致力于为缺医少药的患者群体提供易用性、可及性更高的治疗选择。
NRDY vs XERS — 直观对比
营收规模更大
XERS
是对方的1.7倍
$49.1M
营收增速更快
XERS
高出40.4%
2.3%
净利率更高
XERS
高出31.7%
-18.8%
两年增速更快
XERS
近两年复合增速
-4.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $49.1M | $85.8M |
| 净利润 | $-9.2M | $11.1M |
| 毛利率 | 51.0% | — |
| 营业利润率 | -28.3% | 19.5% |
| 净利率 | -18.8% | 12.9% |
| 营收同比 | 2.3% | 42.8% |
| 净利润同比 | 8.9% | 316.7% |
| 每股收益（稀释后） | $-0.07 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRDYXERS
| Q4 25 | $49.1M | $85.8M | ||
| Q3 25 | $37.0M | $74.4M | ||
| Q2 25 | $45.3M | $71.5M | ||
| Q1 25 | $47.6M | $60.1M | ||
| Q4 24 | $48.0M | $60.1M | ||
| Q3 24 | $37.5M | $54.3M | ||
| Q2 24 | $51.0M | $48.1M | ||
| Q1 24 | $53.7M | $40.6M |
净利润NRDYXERS
| Q4 25 | $-9.2M | $11.1M | ||
| Q3 25 | $-12.3M | $621.0K | ||
| Q2 25 | $-7.9M | $-1.9M | ||
| Q1 25 | $-10.5M | $-9.2M | ||
| Q4 24 | $-10.1M | $-5.1M | ||
| Q3 24 | $-15.9M | $-15.7M | ||
| Q2 24 | $-9.1M | $-15.0M | ||
| Q1 24 | $-7.4M | $-19.0M |
毛利率NRDYXERS
| Q4 25 | 51.0% | — | ||
| Q3 25 | 62.9% | — | ||
| Q2 25 | 61.5% | — | ||
| Q1 25 | 58.0% | — | ||
| Q4 24 | 66.6% | — | ||
| Q3 24 | 70.5% | — | ||
| Q2 24 | 65.7% | — | ||
| Q1 24 | 68.0% | — |
营业利润率NRDYXERS
| Q4 25 | -28.3% | 19.5% | ||
| Q3 25 | -51.5% | 9.0% | ||
| Q2 25 | -27.1% | 6.3% | ||
| Q1 25 | -34.8% | -5.1% | ||
| Q4 24 | -34.0% | 2.8% | ||
| Q3 24 | -68.5% | -23.8% | ||
| Q2 24 | -29.9% | -17.0% | ||
| Q1 24 | -23.9% | -35.1% |
净利率NRDYXERS
| Q4 25 | -18.8% | 12.9% | ||
| Q3 25 | -33.2% | 0.8% | ||
| Q2 25 | -17.4% | -2.7% | ||
| Q1 25 | -22.1% | -15.3% | ||
| Q4 24 | -21.1% | -8.5% | ||
| Q3 24 | -42.4% | -29.0% | ||
| Q2 24 | -17.8% | -31.2% | ||
| Q1 24 | -13.9% | -46.7% |
每股收益（稀释后）NRDYXERS
| Q4 25 | $-0.07 | $0.07 | ||
| Q3 25 | $-0.10 | $0.00 | ||
| Q2 25 | $-0.07 | $-0.01 | ||
| Q1 25 | $-0.09 | $-0.06 | ||
| Q4 24 | $-0.09 | $-0.02 | ||
| Q3 24 | $-0.14 | $-0.11 | ||
| Q2 24 | $-0.08 | $-0.10 | ||
| Q1 24 | $-0.07 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.9M | $111.0M |
| 总债务越低越好 | — | $220.3M |
| 股东权益账面价值 | $19.0M | $13.7M |
| 总资产 | $76.2M | $383.5M |
| 负债/权益比越低杠杆越低 | — | 16.10× |
8季度趋势，按日历期对齐
现金及短期投资NRDYXERS
| Q4 25 | $47.9M | $111.0M | ||
| Q3 25 | $32.7M | $91.6M | ||
| Q2 25 | $36.7M | $59.3M | ||
| Q1 25 | $44.9M | $58.4M | ||
| Q4 24 | $52.5M | $71.6M | ||
| Q3 24 | $65.0M | $69.4M | ||
| Q2 24 | $69.8M | $77.6M | ||
| Q1 24 | $77.0M | $87.4M |
总债务NRDYXERS
| Q4 25 | — | $220.3M | ||
| Q3 25 | — | $219.5M | ||
| Q2 25 | — | $218.6M | ||
| Q1 25 | — | $229.8M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $216.2M | ||
| Q2 24 | — | $230.5M | ||
| Q1 24 | — | $229.7M |
股东权益NRDYXERS
| Q4 25 | $19.0M | $13.7M | ||
| Q3 25 | $24.3M | $-861.0K | ||
| Q2 25 | $31.8M | $-19.3M | ||
| Q1 25 | $34.4M | $-35.1M | ||
| Q4 24 | $39.5M | $-29.6M | ||
| Q3 24 | $43.3M | $-28.3M | ||
| Q2 24 | $52.2M | $-19.3M | ||
| Q1 24 | $52.8M | $-9.2M |
总资产NRDYXERS
| Q4 25 | $76.2M | $383.5M | ||
| Q3 25 | $70.4M | $370.2M | ||
| Q2 25 | $73.7M | $334.7M | ||
| Q1 25 | $83.0M | $315.5M | ||
| Q4 24 | $92.5M | $323.1M | ||
| Q3 24 | $106.8M | $321.1M | ||
| Q2 24 | $111.3M | $331.7M | ||
| Q1 24 | $121.3M | $336.6M |
负债/权益比NRDYXERS
| Q4 25 | — | 16.10× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $20.0M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | — |
| 自由现金流率自由现金流/营收 | -8.7% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | $-24.2M | — |
8季度趋势，按日历期对齐
经营现金流NRDYXERS
| Q4 25 | $-2.9M | $20.0M | ||
| Q3 25 | $-2.4M | $18.4M | ||
| Q2 25 | $-7.0M | $182.0K | ||
| Q1 25 | $-6.4M | $-10.0M | ||
| Q4 24 | $-11.3M | $2.0M | ||
| Q3 24 | $-3.1M | $-8.3M | ||
| Q2 24 | $-5.6M | $-10.3M | ||
| Q1 24 | $4.4M | $-20.3M |
自由现金流NRDYXERS
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-8.2M | — | ||
| Q1 25 | $-7.6M | — | ||
| Q4 24 | $-12.5M | — | ||
| Q3 24 | $-5.0M | — | ||
| Q2 24 | $-7.1M | — | ||
| Q1 24 | $2.1M | — |
自由现金流率NRDYXERS
| Q4 25 | -8.7% | — | ||
| Q3 25 | -11.2% | — | ||
| Q2 25 | -18.1% | — | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | -26.0% | — | ||
| Q3 24 | -13.3% | — | ||
| Q2 24 | -14.0% | — | ||
| Q1 24 | 4.0% | — |
资本支出强度NRDYXERS
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 4.1% | — |
现金转化率NRDYXERS
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 29.68× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NRDY
暂无分部数据
XERS
| Products | $83.4M | 97% |
| Other | $2.4M | 3% |
